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~ Combined Radiofrequency Ablation-Cooling 
Catheter for  Reversible Mapping and Ablat ion  
Fred Shu, Victor Lee, Mark Pomeranz, Wilber Su, David Meinick, 
Munther Homoud, Carotiee Fcote. N.A. Mark Estes 111, Paul J. Wang. New 
England Medical Center, Boston, MA; Cardiac Pathways, Inc., Sunnyvale, 
CA 
Reversible mapping of cardiac arrhythmias has been performed intrsope:a- 
lively with a 0 Q C cooling source. However, a steerable cooling catheter for 
reversible mapping has not yet been developed. We therefore developed 
and tested a COoling system consisting of a -17 degree G hypertonlc saline 
resen~oir and a 7F steerable catheter also capable ot radiofrequePcy abla- 
tion (RF). Using excised ovine hearts placed in a 37 degree circulating saline 
bath, we measured the temperatures (TEMP) at depths of 0 ram, 1 ram, and 
2mm: 
16 1 
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Time in Sac. 
The TEMP after 90 seconds of cooling was 16.45 ± 2,11~ C at O rnm 
compared to 23.92 d: 4.11 ~ C at 1 mm and 31.07 ± 3.89 ~ C at 2 mm depth (p < 
0,001). These data suggest that a 7F steerable combined RF ablation-cooling 
catheter may achieve TEMP suitable for mapping such arrhythmias uch as 
atdal tachycardias and right ventdcular outflow tract tachycardias. Further 
enhancements to achieve lower temperatures at depth may be needed to 
reversibly map other arrhythmais uch as left ventricular techycardias, 
11:30 ~ RF Ablat ion in the Coronary Venous System Is 
Associated With Risk of Coronary Artery Injury 
Which  May Be Prevented by Use o f  Intravascular 
Ultrasound 
Mauriclo Arruda, Hircshi Nakagawa, K Chandrasekaran, Kenichiro Otomo, 
Xunzhang Wang, Karen Beckman, James McClelland, Mado Gonzalez, 
Lawrence Widman, Dwight Reynolds, Ralph Lazzara, Warren Jackman, 
University of Oklahoma, Oklahoma, Ci~ OK 
Sixty SiX patients with epicardial posteroseptal or left posterior accessory AV 
pathways (AP) required ablation from the middle cardiac vein (MCV), a core- 
nary sinus diverticulum or other branch or anomaly of the COronary venous 
system (CVS). 50/66 pts had a previous unsuccessful ablation procedure. 
Ablation within the CVS was pedoi;ned with a 4 mm (n = 52) or 8 mm (n = 
5) non-irdgated electrode or 5 mm irrigated electrode (n = 9). Ablation was 
successful in all but I lot (pt # 2) who had tamponade after ablation in a small 
vein with a 4 mm electrode. The successful RF application was delivered at 
52 + 8 volts (29 :k 10 watts) for 64 :t: 57 seconds. Coronary arteriog,"aphy 
was performed before and after ablation with an irrigated electrode in 9 pts. 
After ablation the distal right coronary artery (RCA) adjacent to the MCV had 
70% and 78% narrowing In 2 pts with no ST changes or CK-MB rise and 
was occluded in 1 pt producing a small-posterobasal infarct. In the first 2 pts, 
the narrowing was completely resolved at 6 months. In the ;attar lot, PTGA 
opened the artery, but there was a 60% residual stenosis at 6 months. NO 
ECG or CK.MB changes were present in the 57 pts who did not undergo 
arteriography alter ablation. 
Further ablations within the CVS were postponed until animal studies 
using an intravascular ultrasound (IVUS) probe in the artery adjacent to the 
ablation electrode snowed that terminating the RF application at the onset of 
echo changes in the artedal wall (increased echogenlclty or wall thickness) 
prevented significant artedal injury. RF was then delivered in the MCV in 1 pt 
at 40--46 volts (17-24 watts) and 2 of the 3 RF applications were terminated 
at 34 and 44 seconds at the onset of increased arterial wall echogenic ~y and 
wall thickness. Ablation was successful and resulted in little or no (< 10%) 
narrowing ol the adjacent RCA. 
Conclusions: RF ablation within the CVS can result in transient or perma- 
nent nan'owing of the adjacent coronary artery. The use of IVUS within the 
coronary artery may allow successful AP ablation within the CVS without 
significant injury to the adjacent coronary artery. 
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[7--4-7--~] Echo~liog~phl~lly-Guided I~Jo~llal Lesion 
Appllcatlen Using Radiofraquen©y Energy in a 
Porcine Model 
Volker Menz, Jlan-Fang Ren, John J. Michele, Stephen M. Dillon, David 
J. Callans, Chades D. Gotflieb, Francis E. Mamhlinskl, David Schwarlzman. 
Philadelphia Heart Institute. Philadelphia PA 
The accuracy of a new technique for guiding radlefrequency energy (RF) 
application was assessed in 15 large (80-120 kg) pigs. Twelve echocer- 
dingraphically distinct endocardial sites were targeted: 1. cdsta terminatis at 
the junction of the SVC odflce; 2. center of the Isthmus between IVC orifice 
and tricuspid valve; 3. os of the coronary sinus; 4. fussa ova,s; 5. lateral 
tdcuspid annulus at the junction of the postedor and anterior tricuspid valve 
leaflets; 6. right ventdcular outflow tract at the base of the septal leaflet of 
the pulmonlc valve; 7. os left or right superior pulmonary vein; 8. supedor 
border of the os of the left atrial apper~qge: 9. posterior AV dng at the base 
of the mitral leaflet; 10. anterior AV dng at the base of the mitral leaflet; 11. 
~,,pex of the antemlateral LV papillary muscle; 12. apex of the postereme- 
dial LV papillary muscle. A commercial ablation catheter (4 mm electrode) 
was gL, Ided to each site utilizing either intreoardiao (12.5 MHz) or multlplane 
transesophageal (5 MHz) echoc~rdiogrephy. The ablation electrode was fit- 
ted with a passive plezoeleotdc transducer which indicated its position on 
the echocardiographic image. RF was applied at each site. The distance 
between the center of the lesion and the site (D, ram) was measured. Result 
[mean 4- SD, (range); D = 0 denotes precise localizat!,)n]: 
SITE 1 2 3 4 5 6 
1.1±2.8 O-~O 020 3.7 :E 9.8 1.7+2.9 020  
(0-~) (0) (0) (O-26) (O-S) (O) 
SiTE 7 8 9 10 11 12 
3.8 -~ 5.2 5.6"4"5,2 O:l:0 2.5 d: 4,9 6.1 +13 9.0210 
(0-10) (0-10) (0) (0-13) (0-40) (0-30) 
Conclusion: Certain endocardial sites were consistently targeted with high 
accuracy, while at other sites were inconsistently targeted. Further evaluation 
of the utility of echocardiography in catheter ablation is warranted. 
Transesophageal Echocardiography in 
Evaluation of Patients With Arterial Embolism 
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~Lef f  Atrial Size, Spontaneous Contrast, and Atrial 
Appendage Peak Flow Velocity in Relation to 
Durat ion  o! Atr ial  Fibri l lat ion 
Patrick M.J. Ver'norst, Otto Kamp, Roelof C. Welling, Cees A. Visser. Free 
University Hospifa;, Amsterdam, NL 
Transesophagasl ~hocardiographic studies have shown that increased k~,'t 
.:.trial (LA) size, r:,eeence of LA spontaneous contrast (LASC +), and low 
LA appendage (LAA) peak flow velocity (pfv), are associated with increased 
thrombeembolic risk in patients with atrial fibrillation (AF). However, their 
relation with the duration of AF is nol well known. Using traneesophegeel 
echocardiography, 165 patients with AF of known duration were studied, in 
whom LA size (cm=), presence of LASC (+), and LAA-pfv (cm/sec), were 
related to duration (months) of AF. Results: 
AF duration (months) 
< 1 1--3 3-12 > 12 
in = 44) (n = 34) (n = 33) (n = 54) 
LA slze 20.1 2 7.1" 21.6 :E 6.3 P.2.8 2 7.6 23.2275" 
LASC + 15 (34=/0) * 15 (44%) 12 (36%) 32 (59%)* 
LAA.pIv 36 :E 19 *# 29 4:21 27 d: 12 = 24:1: 20# 
°p < 0.05;#p ,< 0.005 
No differences in baseline characteristics (age, gender, etiology of AF) 
were observed among the 4 groups. 
Conclusions: 
I.A size and presence of LASC are directly, and LAA-pfv is inversely related 
to duration of AF. In time, LAA-pfv decreases earlier and more pronounced 
than LA size increase and LASC occurrence. LAA-pfv might be used in the 
management of patients with AF, especially when AF duration is unknown. 
